Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology. 2020;158:1851–64.

Article  CAS  PubMed  Google Scholar 

Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18:223–38.

Article  PubMed  Google Scholar 

Makri E, Goulas A, Polyzos SA. Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res. 2021;52:25–37.

Article  CAS  PubMed  Google Scholar 

Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7:851–61.

Article  PubMed  Google Scholar 

Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4:389–98.

Article  PubMed  Google Scholar 

Shiha G, Alswat K, Al Khatry M, Sharara AI, Örmeci N, Waked I, Benazzouz M, Al-Ali F, Hamed AE, Hamoudi W, et al. Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa. Lancet Gastroenterol Hepatol. 2021;6:57–64.

Article  PubMed  Google Scholar 

Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, Colombo M, Craxi A, Crespo J, Day CP, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69:896–904.

Article  PubMed  Google Scholar 

Ogrodnik M, Miwa S, Tchkonia T, Tiniakos D, Wilson CL, Lahat A, Day CP, Burt A, Palmer A, Anstee QM, et al. Cellular senescence drives age-dependent hepatic steatosis. Nat Commun. 2017;8:15691.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gong Z, Tas E, Yakar S, Muzumdar R. Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. Mol Cell Endocrinol. 2017;455:115–30.

Article  CAS  PubMed  Google Scholar 

Golabi P, Paik J, Reddy R, Bugianesi E, Trimble G, Younossi ZM. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC Gastroenterol. 2019;19:56.

Article  PubMed  PubMed Central  Google Scholar 

Alqahtani SA, Schattenberg JM. NAFLD in the Elderly. Clin Interv Aging. 2021;16:1633–49.

Article  PubMed  PubMed Central  Google Scholar 

Zhao YC, Zhao GJ, Chen Z, She ZG, Cai J, Li H. Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension. Hypertension. 2020;75:275–84.

Article  CAS  PubMed  Google Scholar 

Kasper P, Martin A, Lang S, Kutting F, Goeser T, Demir M, Steffen HM. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2021;110:921–37.

Article  PubMed  Google Scholar 

Petroni ML, Brodosi L, Bugianesi E, Marchesini G. Management of non-alcoholic fatty liver disease. BMJ. 2021;372:m4747.

Article  PubMed  Google Scholar 

Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022;10:284–96.

Article  PubMed  Google Scholar 

Zhang Q, Zhu Y, Yu W, Xu Z, Zhao Z, Liu S, Xin Y, Lv K. Diagnostic accuracy assessment of molecular prediction model for the risk of NAFLD based on MRI-PDFF diagnosed Chinese Han population. BMC Gastroenterol. 2021;21:88.

Article  PubMed  PubMed Central  Google Scholar 

Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. J Hepatol. 2018;68:305–15.

Article  CAS  PubMed  Google Scholar 

Sheng GT, Lu S, Xie QY, Peng N, Kuang MB, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease. Lipids Health Dis. 2021;20:134.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee J-H, Kim D, Kim HJ, Lee C-H, Yang JI, Kim W, Kim YJ, Yoon J-H, Cho S-H, Sung M-W, Lee H-S. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Digest Liver Dis. 2010;42:503–8.

Article  CAS  Google Scholar 

Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y-X, Liu X, Cen C, Li X, Liu J-M, Ming Z-Y, Yu S-F, Tang X-F, Zhou L, Yu J, et al. Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study. Hepatobiliary Pancreat Dis Int. 2021;20:409–15.

Article  PubMed  Google Scholar 

Rodriguez LA, Shiboski SC, Bradshaw PT, Fernandez A, Herrington D, Ding J, Bradley RD, Kanaya AM. Predicting Non-Alcoholic Fatty Liver Disease for Adults Using Practical Clinical Measures: Evidence from the Multi-ethnic Study of Atherosclerosis. J Gen Intern Med. 2021;36:2648–55.

Article  PubMed  PubMed Central  Google Scholar 

Cen C, Wang W, Yu S, Tang X, Liu J, Liu Y, Zhou L, Yu J, Zheng S. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease. Hep Intl. 2020;14:808–16.

Article  Google Scholar 

Wang J, Ma L, Chen S, Xu L, Miao M, Yu C, Li Y, Xu C. Risk for the development of non-alcoholic fatty liver disease: a prospective study. J Gastroenterol Hepatol. 2018;33:1518–23.

Article  CAS  PubMed  Google Scholar 

Zhou B, Gong N, Huang X, Zhu J, Qin C, He Q. Development and validation of a nomogram for predicting metabolic-associated fatty liver disease in the Chinese physical examination population. Lipids Health Dis. 2023;22:85.

Article  PubMed  PubMed Central  Google Scholar 

Liang Y, Ye M, Hou X, Chen P, Wei L, Jiang F, Feng L, Zhong L, Liu H, Bao Y, Jia W. Development and validation of screening scores of non-alcoholic fatty liver disease in middle-aged and elderly Chinese. Diabetes Res Clin Pract. 2020;169: 108385.

Article  CAS  PubMed  Google Scholar 

Tukey JW. Exploratory Data Analysis. Reading, MA: Addison-Wesley; 1977.

Google Scholar 

Fan JG, Jia JD, Li YM, Wang BY, Lu LG, Shi JP, Chan LY. Chinese Association for the Study of Liver D: Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163–166). J Dig Dis. 2011;12:38–44.

Article  PubMed  Google Scholar 

Kidd AC, McGettrick M, Tsim S, Halligan DL, Bylesjo M, Blyth KG. Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors. BMJ Open Respir Res. 2018;5:e000240.

Article  PubMed  PubMed Central  Google Scholar 

Hu YH, Shi R, Mo RH, Hu F. Nomogram for the prediction of diabetic nephropathy risk among patients with type 2 diabetes mellitus based on a questionnaire and biochemical indicators: a retrospective study. Aging-Us. 2020;12:10317–36.

Article  CAS  Google Scholar 

Wang H, Zhang L, Liu Z, Wang X, Geng S, Li J, Li T, Ye S. Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram. Patient Prefer Adherence. 2018;12:1757–65.

Article  PubMed  PubMed Central  Google Scholar 

McEligot AJ, Poynor V, Sharma R, Panangadan A. Logistic LASSO regression for dietary intakes and breast cancer. Nutrients. 2020;12:2652.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Mach Learn. 2002;46:389–422.

Article  Google Scholar 

Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, McGinn T, Guyatt G. Discrimination and calibration of clinical prediction models: users’ guides to the medical literature. JAMA. 2017;318:1377–84.

Article  PubMed  Google Scholar 

Kerr KF, Brown MD, Zhu K, Janes H. Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol. 2016;34:2534–40.

Article  PubMed  PubMed Central  Google Scholar 

Zhu J-Z, Zhou Q-Y, Wang Y-M, Dai Y-N, Zhu J, Yu C-H, Li Y-M. Prevalence of fatty liver disease and the economy in China: a systematic review. World J Gastroenterol. 2015;21:5695–706.

Article  PubMed  PubMed Central  Google Scholar 

Polyzos SA, Mantzoros CS. Leptin in health and disease: facts and expectations at its twentieth anniversary. Metabolism. 2015;64:5–12.

Article  CAS  PubMed  Google Scholar